Literature DB >> 8013522

Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion.

D Mathey1, J Schofer, H J Schäfer, T Hamdoch, H C Joachim, A Ritgen, F Hugo, S Bhakdi.   

Abstract

The terminal, membrane-damaging complement complex C5b-9 accumulates in the infarcted myocardium. In experimental myocardial infarction, we investigated the time course of C5b-9 deposition and the influence of reperfusion. In a group of 17 rabbits (group 1), the circumflex coronary artery was occluded for different time periods ranging from 0.5 to 29 h without subsequent reperfusion. A second group of 23 rabbits (group 2) underwent coronary artery occlusion for periods ranging from 0.5 to 6 h followed by reperfusion. C5b-9 was determined in transmural myocardial biopsies by immunohistochemistry and by ELISA. In group 1, C5b-9 accumulation in the ischaemic myocardium was found only after 5 to 6 h of coronary artery occlusion. In group 2 (ischaemia and reperfusion), significant C5b-9 deposition was already observed after 30 min of myocardial ischaemia. We conclude that in the absence of reperfusion C5b-9 accumulation occurs as a late event when most of the jeopardized myocardium has probably already become necrotic. In the presence of reperfusion, however, the complement system is activated rapidly and this could play a role in the pathogenesis of reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013522     DOI: 10.1093/oxfordjournals.eurheartj.a060516

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

1.  Reperfusion Stimulated Inflammatory Response: Role in Lethal Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

3.  Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligation in rats.

Authors:  Miriyala Sumitra; Panchatcharam Manikandan; Mohammed Nayeem; Bhakthavatsalam Murali Manohar; Beema Lokanadam; Subbiah Vairamuthu; Samu Subramaniam; Rengarajulu Puvanakrishnan
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

4.  The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.

Authors:  Fengxin Lu; Stacey M Fernandes; Alvin E Davis
Journal:  Cardiovasc Pathol       Date:  2012-06-16       Impact factor: 2.185

5.  Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.

Authors:  Reinhard J Sauter; Manuela Sauter; Edimara S Reis; Frederic N Emschermann; Henry Nording; Sonja Ebenhöch; Peter Kraft; Patrick Münzer; Maximilian Mauler; Johannes Rheinlaender; Johannes Madlung; Frank Edlich; Tilman E Schäffer; Sven G Meuth; Daniel Duerschmied; Tobias Geisler; Oliver Borst; Meinrad Gawaz; Christoph Kleinschnitz; John D Lambris; Harald F Langer
Journal:  Circulation       Date:  2018-10-16       Impact factor: 29.690

6.  Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections.

Authors:  J P Doran; A J Howie; J N Townend; R S Bonser
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

7.  Detection of early myocardial cell death in owl monkeys (Aotus nancymai) using complement component C9 immunohistochemistry in formalin-fixed paraffin-embedded heart tissues: A retrospective study.

Authors:  Alfonso S Gozalo; Lynn E Lambert; Patricia M Zerfas; William R Elkins
Journal:  J Med Primatol       Date:  2021-12-31       Impact factor: 0.821

8.  High prevalence of acute myocardial damage in a hospital necropsy series, shown by C9 immunohistology.

Authors:  M A Ferreira; H E Owen; A J Howie
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

9.  Pexelizumab and survival in cardiac surgery.

Authors:  L Testa; M Meco; S Cirri; F Bedogni
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2011

Review 10.  New insights of an old defense system: structure, function, and clinical relevance of the complement system.

Authors:  Christian Ehrnthaller; Anita Ignatius; Florian Gebhard; Markus Huber-Lang
Journal:  Mol Med       Date:  2010-10-29       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.